North America Point Of Care Diagnostics Market Worth $28.46 Billion By 2030

January 2023 | Report Format: Electronic (PDF)

North America Point Of Care Diagnostics Market Growth & Trends

The North America point of care diagnostics market size is expected to reach USD 28.46 billion by 2030, expanding at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to the rise in the geriatric population and the ability of point-of-care (POC) diagnostic tests to deliver immediate results. Furthermore, a rise in funding from the government & private institutions is a key factor driving the industry’s growth. An increase in the adoption of mobile diagnostic devices in the region is also one of the key factors driving demand for POC testing.

An increase in funding from multiple sources, including the U.S. department of defense (DOD), NIH, and private foundations such as the Bill & Melinda Gates Foundation, is expected to drive the market’s growth. For instance, Grand Challenges Canada and the Bill & Melinda Gates Foundation have launched a joint initiative for POC diagnostics. These organizations are involved in the development and integration of different diagnostic components into interoperable POC platforms with “plug-and-play” characteristic features and the capability of running diverse tests from various developers. Research is conducted to incorporate each test on a common platform with a single interface, enabling analysis of different sample specimens using various approaches for analysis.

Such institutions are involved in funding various projects for the development of POC diagnostics to different organizations including California Institute of Technology, Dartmouth College, and Seventh Sense Biosystems. Moreover, NIH, through the Point-of-Care Technologies Research Network, has been funding the development of these technologies for screening infectious diseases & cancer as well as for primary care. In August 2022, Nanopath, Inc. received funding of USD 10 million from Medtech Convergence Fund and Norwest Venture Partners with participation from Green D Ventures and Gingerbread Capital. The funding would help develop POC diagnostics for women’s health.

Key players operating in the market are focusing on collaboration for the development of new products. For instance, in December 2021, QIAGEN and Denovo Biopharma LLC announced a partnership to establish a blood-based companion diagnostic test. Moreover, the companies are also emphasizing on launching of innovative technologies to increase the efficiency of diagnostic testing. For instance, in 2021, F. Hoffmann-La Roche Ltd launched a new blood glucose meter Accu-Chek Instant system, which helped the company expand its personalized diabetes management business.

key Request a free sample copy or view report summary: North America Point Of Care Diagnostics Market Report

North America Point Of Care Diagnostics Market Report Highlights

The growth of the overall market is attributed to the increasing emphasis on point-of-care testing due to superior efficiency and minimal diagnostic turnaround time
Increase in funding from multiple sources, including the U.S. department of defense (DOD), NIH, and private foundations such as the Bill & Melinda Gates Foundation is expected to increase the launch of new PoC diagnostic technologies in North America
The infectious diseases product segment held the largest market share owing to the substantial adoption of COVID-19 diagnostic kits and the introduction of new PoC kits for respiratory conditions
The clinic end-use segment dominated the market with the highest revenue share in 2022. This is attributed to the population’s preference for clinics due to convenience
The LDT type segment held a marginal share of the North America PoC diagnostics industry in 2022, owing to stringent authority regulations
The U.S. dominated the market in 2022, due to the presence of key players and the rising support from the government for the development of advanced technologies

North America Point Of Care Diagnostics Market Segmentation

Grand View Research has segmented the North America point of care diagnostics market based on product, type, end-use, and country:

North America Point-of-care Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

Glucose Testing
- By End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
      - Rural Health Clinic
      - Federally Qualified Health Clinic (FQHC)
- By Disease
  - Diabetes
  - Others
HbA1c Testing
- By End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
      - Rural Health Clinic
      - Federally Qualified Health Clinic (FQHC)
- By Disease
  - Diabetes
  - Others
- Coagulation
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Thrombosis
    - Hemophilia
    - Others
- Fertility/Pregnancy
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - LH- Ovulation Elite Test
    - HCG- Pregnancy Tests
    - Fertility Tests
    - Others
- Infectious Diseases
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
- Cardiac Markers
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Acute Coronary Syndrome
    - Myocardial Infarction
    - Congestive Heart Failure
    - Others
  - By Marker
    - Troponin
    - CK-MB
    - Myoglobin
    - BNP and NT-proBNP
    - Others
- Thyroid Stimulating Hormone
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Hyperthyroidism
    - Hypothyroidism
    - Hematology
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Anemia
    - Leukemia
    - Others
- Primary Care Systems
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
        
        Decentralized Clinical Chemistry
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
- Feces
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Colorectal Cancer
    - GI Disorders
    - Others
- Lipid Testing
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Hyperlipidemia
    - Cardiovascular Diseases
    - Others
- Cancer Marker
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - Breast Cancer
    - Lung Cancer
    - Colon Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Skin Cancer
    - Kidney Cancer
    - Bladder Cancer
    - Others
  - By Marker
    - ALK gene rearrangements and overexpression
    - Alpha-fetoprotein (AFP)
    - BCL2 gene rearrangement
    - Bladder Tumor Antigen (BTA)
    - BRCA1 and BRCA2 gene mutations
    - BRAF V600 mutations
    - CA15-3/CA27.29
    - Carcinoembryonic antigen (CEA)
    - PSA
    - Others
- Blood Gas/Electrolytes
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
- Ambulatory Chemistry
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
- Drug Abuse Testing
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
- Urinalysis/Nephrology
  - By End-use
    - Hospitals
    - Laboratories
    - Home Care
    - Clinic
      - Physician Office
      - Pharmacy & Retail Clinics
      - Non-practice Clinics
      - Urgent Care Clinics
      - Others
        
        Rural Health Clinic
        
        Federally Qualified Health Clinic (FQHC)
  - By Disease
    - UTI
    - Kidney Disease
    - Diabetes
    - Others

North America Point-of-care Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals
Laboratories
Home Care
- Self-testing
- Self-collection
Clinic
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
  - Rural Health Clinic
  - Federally Qualified Health Clinic (FQHC)

North America Point-of-care Diagnostics Type Outlook (Revenue, USD Million, 2018 - 2030)

LDTs
Others

North America Point-of-care Diagnostics Country Outlook (Revenue, USD Billion, 2018 - 2030)

U.S.
Canada

List of Key Players in North America Point Of Care Diagnostics Market

F. Hoffmann-La Roche AG
QIAGEN
Danaher Corporation
BD
bioMérieux SA
Abbott
Siemens Healthineers A.G.
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical
Trividia Health, Inc.
Quidel Corporation
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies, Inc.
NIPRO
Spectral Medical, Inc.

Request a Free Sample

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

We are committed towards customer satisfaction, and quality service.

Client Testimonials

"The quality of research they have done for us has been excellent..."

Brian Moore, VP, NICCA USA, Inc. testimonials More

ESOMAR Certified & Member

Privacy & Security Compliance

trustwave Validate

Payment & Banking Partners

authorize.net